| 000 | 01300 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515210110.0 | ||
| 264 | 0 | _c20100728 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/092986710790980050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPertwee, R G | |
| 245 | 0 | 0 |
_aReceptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2010 |
||
| 300 |
_a1360-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aCannabinoid Receptor Agonists |
| 650 | 0 | 4 | _aCannabinoid Receptor Antagonists |
| 650 | 0 | 4 |
_aDronabinol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aIon Channels _xmetabolism |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aPiperidines _xchemistry |
| 650 | 0 | 4 |
_aPyrazoles _xchemistry |
| 650 | 0 | 4 |
_aReceptors, Cannabinoid _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xmetabolism |
| 650 | 0 | 4 | _aRimonabant |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 17 _gno. 14 _gp. 1360-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986710790980050 _zAvailable from publisher's website |
| 999 |
_c19536400 _d19536400 |
||